Yan Shen
- Surgery top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Epidemiology top 10%
- Oncology top 10%
- Topics
- Viral Infections and Immunology Research (10 papers)Thyroid Cancer Diagnosis and Treatment (8 papers)interferon and immune responses (7 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yan Shen
76 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Surgery 407
- Molecular Biology 380
- Pulmonary and Respiratory Medicine 319
- Epidemiology 274
- Oncology 240
Countries citing papers authored by Yan Shen
This map shows the geographic impact of Yan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Shen more than expected).
Fields of papers citing papers by Yan Shen
This network shows the impact of papers produced by Yan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Shen. The network helps show where Yan Shen may publish in the future.
Co-authorship network of co-authors of Yan Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Yan Shen. A scholar is included among the top collaborators of Yan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Shen. Yan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinomabreakdown → | 161 |
| 4 | 10 | |
| 5 | 17 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 10 | |
| 9 | 27 | |
| 10 | The Combined Use of Chemotherapy and Radiotherapy with PD-1 Inhibitor, Pembrolizumab, in Advanced Cervical Cancer: A Case Report | 1 |
| 11 | 50 | |
| 12 | 18 | |
| 13 | 5 | |
| 14 | 48 | |
| 15 | 12 | |
| 16 | 16 | |
| 17 | 33 | |
| 18 | 2 | |
| 19 | 4 | |
| 20 | 5 |
About Yan Shen
Yan Shen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Hepatology, having authored 77 papers that have together received 1.7k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (10 papers), Thyroid Cancer Diagnosis and Treatment (8 papers) and interferon and immune responses (7 papers). The work is most often cited by research in Hepatology (211 citations), Endocrinology, Diabetes and Metabolism (232 citations) and Pulmonary and Respiratory Medicine (319 citations). Yan Shen has collaborated with scholars based in China, United States and France. Frequent co-authors include Wei Xu, Yiwei Chu, Sidong Xiong, Chuan‐Xi Zhang, Yuxuan Ye, Shusen Zheng, Libo Chen, Xiao Xu, Qinghong Ke and Bernard Moussian. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.